Clinical focus: Interpreting blood sugar tests means integrating the result, sampling conditions, symptoms, HbA1c, ketones, electrolytes and the patient’s illness. A number is not a diagnosis by itself. Use a laboratory method and local reference ranges for diagnosis, and treat immediately when hypoglycaemia or a hyperglycaemic emergency is suspected.
Learning objectives
- Convert and interpret glucose in mg/dL and mmol/L, and recognise pre-analytical errors.
- Use fasting, random, 2-hour oral glucose tolerance and HbA1c results to classify normal glycaemia, prediabetes and diabetes.
- Interpret capillary bedside testing, continuous glucose monitoring (CGM), urine/blood ketones and urinary glucose.
- Recognise hypoglycaemia, diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS), stress hyperglycaemia and euglycaemic DKA.
- Apply targets safely, identify discordant results and plan repeat testing, escalation and monitoring.
1. Units and the first safety checks
Glucose is reported as either mg/dL or mmol/L. The bedside conversion is:
mmol/L = mg/dL ÷ 18 and mg/dL = mmol/L × 18.
| Result | Approximate conversion | Immediate interpretation |
|---|---|---|
| 3.0 mmol/L | 54 mg/dL | Clinically significant hypoglycaemia threshold. |
| 3.9 mmol/L | 70 mg/dL | Alert value; treat a symptomatic patient and investigate. |
| 7.0 mmol/L | 126 mg/dL | Fasting diabetes threshold when confirmed by an appropriate laboratory test. |
| 11.1 mmol/L | 200 mg/dL | 2-hour OGTT or random-with-symptoms diabetes threshold. |
| 33.3 mmol/L | 600 mg/dL | Typical HHS-range hyperglycaemia; assess urgently. |
Before interpreting any value, document whether the sample was fasting (at least 8 hours without calories), pre-meal, 1–2 hours after a meal, random, during an illness, after exercise or after glucose-containing treatment. Check the meter strip expiry, hand contamination, sample volume, device calibration and whether capillary blood is appropriate for a shocked or severely dehydrated patient. Confirm unexpected, critical or discordant bedside results with a venous laboratory sample, but do not delay emergency treatment in a symptomatic patient.
2. What each glucose test actually measures
| Test | Time window | Best use | Main limitations |
|---|---|---|---|
| Fasting plasma glucose (FPG) | One point after ≥8-hour fast | Diagnosis and follow-up of diabetes/prediabetes | Stress, infection, sleep loss and fasting errors alter results; requires confirmation if asymptomatic. |
| Random plasma glucose | Any time | Symptomatic patients and emergencies | Meal timing affects it; ≥200 mg/dL diagnoses diabetes only with classic symptoms or crisis. |
| 75-g OGTT | Fasting and 2-hour value after glucose drink | Detects impaired glucose tolerance and diabetes when FPG/A1c is equivocal; pregnancy testing | Preparation, vomiting, acute illness and incorrect timing invalidate results. |
| HbA1c | Approximate weighted mean over 2–3 months (more recent weeks influence it more) | Diagnosis and long-term glycaemic monitoring | Unreliable with altered red-cell survival, haemoglobin variants, recent transfusion, severe anaemia or advanced kidney disease. |
| Capillary point-of-care glucose | Immediate current glucose | Rapid treatment decisions and bedside monitoring | Perfusion, temperature, haematocrit, contamination and device error can bias values. |
| CGM/interstitial glucose | Usually every few minutes with a short physiological lag | Trends, variability, nocturnal hypoglycaemia and time-in-range | Lag during rapid change; confirm a result that does not fit symptoms or before high-risk treatment. |
3. Diagnostic thresholds for non-pregnant adults
The following thresholds are widely used for laboratory plasma glucose and a standardised laboratory HbA1c. In a person without unequivocal symptoms or hyperglycaemic crisis, confirm an abnormal result on another day, preferably with the same test. Marked discordance requires repeat testing and investigation rather than averaging values.
| Category | HbA1c | Fasting plasma glucose | 2-hour 75-g OGTT | Random plasma glucose |
|---|---|---|---|---|
| Normal | <5.7% (<39 mmol/mol) | <100 mg/dL (<5.6 mmol/L) | <140 mg/dL (<7.8 mmol/L) | No diagnostic random cut-off |
| Prediabetes | 5.7–6.4% (39–46 mmol/mol) | 100–125 mg/dL (5.6–6.9 mmol/L) | 140–199 mg/dL (7.8–11.0 mmol/L) | No diagnostic random cut-off |
| Diabetes | ≥6.5% (≥48 mmol/mol) | ≥126 mg/dL (≥7.0 mmol/L) | ≥200 mg/dL (≥11.1 mmol/L) | ≥200 mg/dL (≥11.1 mmol/L) with classic symptoms or crisis |
Do not use a portable point-of-care HbA1c alone to diagnose diabetes unless the method is certified and the local policy explicitly allows it. A patient with polyuria, polydipsia, weight loss, blurred vision, vomiting, abdominal pain, altered mental state or dehydration needs immediate clinical assessment—not an outpatient repeat appointment.
4. HbA1c: interpreting the three-month story
Glucose binds non-enzymatically to haemoglobin. HbA1c therefore estimates average glycaemia, but it does not show daily peaks, variability or recent hypoglycaemia. As a rough educational conversion, estimated average glucose (mg/dL) is approximately 28.7 × HbA1c − 46.7; this is not a substitute for a meter or CGM.
| HbA1c interpretation | Clinical meaning |
|---|---|
| Near target but symptomatic lows | Possible overtreatment or wide variability; review glucose logs and medication timing rather than intensifying treatment. |
| High A1c with normal clinic glucose | Missed post-meal or nocturnal hyperglycaemia, adherence variation, meter error or altered red-cell survival. |
| Rapid fall over weeks | May reflect recent treatment or red-cell loss/transfusion; it does not prove stable control. |
| Unreliable A1c | Haemolysis, blood loss, transfusion, erythropoietin, haemoglobin variants, pregnancy, advanced CKD and some haemoglobinopathies. Use plasma glucose, fructosamine/glycated albumin or CGM where appropriate. |
5. Fasting, post-meal and inpatient targets
Targets are individualised by age, pregnancy, comorbidity, hypoglycaemia risk and available resources. For many non-pregnant adults, a common starting outpatient target is pre-meal 80–130 mg/dL (4.4–7.2 mmol/L), peak post-meal below 180 mg/dL (10.0 mmol/L), and HbA1c below 7%; frail adults, older adults and people with recurrent severe hypoglycaemia may need less stringent goals. In most critically ill hospitalised adults, protocols commonly aim for about 140–180 mg/dL (7.8–10.0 mmol/L) and avoid both hypoglycaemia and very tight control. Always apply local protocol.
Pregnancy uses tighter, time-specific targets. Common treatment targets are fasting <95 mg/dL (5.3 mmol/L), 1-hour post-meal <140 mg/dL (7.8 mmol/L) or 2-hour <120 mg/dL (6.7 mmol/L); local obstetric guidelines take precedence.
6. Hypoglycaemia
| Level | Glucose | Meaning and response |
|---|---|---|
| Level 1 (alert) | <70 to ≥54 mg/dL (3.9 to 3.0 mmol/L) | Treat promptly, identify cause and recheck. |
| Level 2 (clinically significant) | <54 mg/dL (<3.0 mmol/L) | Neuroglycopenia is more likely; urgent treatment and observation. |
| Level 3 (severe) | No fixed number | Cognitive/physical impairment requiring another person, regardless of the measured value. |
Immediate treatment (adult educational protocol)
- If awake and able to swallow: give 15–20 g fast-acting carbohydrate (for example glucose tablets or 150–200 mL ordinary sugary drink), recheck in 15 minutes, and repeat until ≥70 mg/dL (3.9 mmol/L). Follow with a meal or longer-acting carbohydrate if the next meal is not soon.
- If confused, seizing, unconscious or unable to swallow: place in the recovery position, protect the airway, give IV dextrose according to local concentration protocol (for example 25 g, such as 50 mL of 50% dextrose, diluted where required) or glucagon 1 mg IM/SC when IV access is unavailable. Recheck frequently and provide ongoing glucose because sulfonylurea or long-acting insulin effects can recur.
- Children, neonates, pregnancy and patients with renal/liver failure need weight- and protocol-specific dosing. Never pour fluid or food into the mouth of an unconscious patient.
Common causes include excess insulin or sulfonylurea, missed meals, vomiting, exercise, alcohol, renal failure and sepsis. Beta-blockers may blunt tremor and palpitations. Recurrent or unexplained hypoglycaemia warrants medication review, renal/liver tests, cortisol assessment or endocrine input.
7. Urine glucose and ketones
Urine glucose is less sensitive and less timely than blood glucose because the renal threshold varies (often around 180 mg/dL/10 mmol/L), and SGLT2 inhibitors intentionally cause glycosuria. It should not be used to diagnose diabetes when blood testing is available.
Ketones indicate increased fat breakdown. Blood beta-hydroxybutyrate is preferred for DKA; urine nitroprusside mainly detects acetoacetate and may lag early or remain positive during recovery. Test ketones in diabetes with vomiting, abdominal pain, rapid breathing, dehydration, pregnancy, prolonged fasting, infection, missed insulin or glucose persistently above the local sick-day threshold (often ≥250 mg/dL/13.9 mmol/L). SGLT2 inhibitors can cause euglycaemic DKA, so normal or only moderately high glucose does not exclude it.
| Blood beta-hydroxybutyrate | Practical interpretation |
|---|---|
| <0.6 mmol/L | Usually normal; interpret with symptoms and trend. |
| 0.6–1.5 mmol/L | Early elevation; hydrate, repeat, check glucose and assess illness/insulin omission. |
| 1.6–3.0 mmol/L | Significant risk; urgent clinical advice and acid–base assessment. |
| ≥3.0 mmol/L | Strongly suggests DKA in the right context; emergency evaluation. |
8. Diabetic ketoacidosis (DKA)
DKA is insulin deficiency with hyperglycaemia or known diabetes, ketonaemia/ketonuria and metabolic acidosis. A current consensus framework uses diabetes/hyperglycaemia (glucose ≥200 mg/dL/11.1 mmol/L or known diabetes), beta-hydroxybutyrate ≥3.0 mmol/L (or urine ketones ≥2+) and pH <7.3 and/or bicarbonate <18 mmol/L. DKA can occur at lower glucose in pregnancy, starvation or SGLT2-inhibitor use.
| Assess | Why it matters |
|---|---|
| Glucose and bedside ketones | Confirms severity and guides the frequency of monitoring. |
| Venous/arterial pH, bicarbonate and anion gap | Quantifies acidosis and follows resolution; calculate AG = Na − (Cl + HCO3). |
| Potassium, sodium, phosphate, urea/creatinine | Total body potassium is depleted even when serum K is normal/high; renal failure changes replacement safety. |
| ECG, infection screen, pregnancy test where relevant | Identifies precipitating illness and potassium toxicity. |
Emergency principles (adult, protocol-dependent)
- Airway, breathing, circulation, cardiac monitoring, two IV lines, strict input/output and frequent neurologic review.
- Start isotonic crystalloid (commonly 500–1000 mL/hour for the first 2–4 hours in adults without heart/renal failure, then tailor to haemodynamics, sodium and urine output).
- Check potassium before insulin. If K <3.3 mmol/L, hold insulin and replace potassium urgently. If K 3.3–5.2, add approximately 20–30 mmol potassium per litre of fluid according to protocol. If K >5.2, do not give potassium initially but recheck frequently.
- Start IV regular insulin commonly at 0.1 units/kg/hour after potassium is safe; a bolus is not routinely required in every protocol. Continue insulin until ketonaemia/acidosis resolves—not merely until glucose falls.
- When glucose falls to about 200 mg/dL (11.1 mmol/L) in DKA, add dextrose (for example 5–10%) so insulin can continue clearing ketones. Replace phosphate only for severe hypophosphataemia with weakness, respiratory or cardiac compromise. Bicarbonate is generally reserved for extreme acidaemia (around pH <7.0) with senior/critical-care guidance.
9. Hyperosmolar hyperglycaemic state (HHS)
HHS usually presents with profound dehydration, very high glucose (often ≥600 mg/dL/33.3 mmol/L), high effective osmolality (about >300 mOsm/kg or total >320), minimal ketones and pH ≥7.3/bicarbonate ≥15 mmol/L. Older adults with type 2 diabetes, infection, stroke, myocardial infarction, steroid exposure or limited access to water are at high risk.
Effective osmolality (mOsm/kg) ≈ 2 × Na (mmol/L) + glucose (mmol/L). Correct sodium and osmolality gradually; a rapid fall can cause cerebral oedema. Fluids are the main initial treatment, with insulin after initial fluid and potassium assessment. Severe HHS, shock, altered consciousness or mixed DKA/HHS requires critical-care management.
10. Stress hyperglycaemia and non-diabetic causes
Catecholamines, cortisol, glucagon and inflammatory cytokines raise glucose during sepsis, trauma, burns, myocardial infarction, stroke and surgery. A single high inpatient glucose may be stress hyperglycaemia, previously unrecognised diabetes or medication-related. Review HbA1c when stable and arrange follow-up rather than labelling the patient on one value.
| Cause of high glucose | Clues |
|---|---|
| Glucocorticoids | Post-meal/afternoon rise after prednisolone or dexamethasone; fasting value may be deceptively normal. |
| Endocrine disease | Cushing syndrome, acromegaly, thyrotoxicosis or pheochromocytoma features. |
| Pancreatic disease | Pancreatitis, pancreatic surgery, haemochromatosis or pancreatic cancer. |
| Drugs | Thiazides, atypical antipsychotics, protease inhibitors, tacrolimus and enteral/parenteral nutrition. |
| Laboratory/collection error | Sugar on fingers, contaminated IV line, old/poorly stored strips or sampling from a glucose-containing infusion. |
11. Discordant or difficult results
- High meter, normal laboratory glucose: wash and dry hands, repeat from a new strip, check sampling site and compare with venous plasma.
- Symptoms but “normal” meter: treat based on clinical risk, repeat with laboratory measurement and check alternative causes such as sepsis, adrenal insufficiency or arrhythmia.
- High HbA1c but normal values today: look for missed post-meal/nocturnal peaks, recent improvement, adherence variability and haemoglobin/renal confounders.
- High glucose plus normal urine ketones: does not exclude DKA early, especially with SGLT2 therapy; use blood beta-hydroxybutyrate and blood gas.
- Low sodium with high glucose: hyperglycaemia shifts water extracellularly; calculate corrected sodium with the local formula and correct osmolality gradually.
- Renal failure: insulin and sulfonylureas may last longer; hypoglycaemia risk rises, while HbA1c may be misleading.
12. A practical interpretation algorithm
- Confirm the sample: fasting/post-meal/random, capillary versus venous, meter quality and contamination.
- Assess symptoms and danger: conscious state, hydration, respiratory pattern, abdominal pain, vomiting, infection and pregnancy.
- Classify the number: low, target, impaired fasting, diagnostic diabetes, severe hyperglycaemia or crisis range.
- Pair glucose with HbA1c, ketones and acid–base tests: never use HbA1c to rule out an acute crisis.
- Check electrolytes and renal function: especially potassium, bicarbonate, sodium, creatinine and osmolality in severe illness.
- Treat first when necessary: give carbohydrate for hypoglycaemia; emergency fluids/insulin/potassium pathway for DKA/HHS under local protocol.
- Document and follow up: cause, medication changes, repeat timing, education, sick-day plan and referral.
13. Worked cases
Case 1: diagnosing diabetes
An asymptomatic adult has FPG 7.4 mmol/L on two separate mornings and HbA1c 6.7%. Both exceed diagnostic thresholds, so diabetes is confirmed after excluding laboratory error and considering conditions that invalidate HbA1c.
Case 2: hypoglycaemia with a normal HbA1c
A patient using basal–bolus insulin has sweating and confusion; capillary glucose is 2.6 mmol/L. Give rapid carbohydrate if safe, or parenteral treatment if not, recheck after 15 minutes and investigate missed meals, renal failure, alcohol, exercise and dosing error. A normal HbA1c does not protect against severe lows.
Case 3: euglycaemic DKA
A patient taking an SGLT2 inhibitor has vomiting, tachypnoea, glucose 9.8 mmol/L, beta-hydroxybutyrate 4.2 mmol/L and bicarbonate 12 mmol/L. The glucose is not high, but the ketonaemia and acidosis are an emergency. Stop the precipitating drug, start the DKA pathway with fluids, insulin and dextrose as indicated, and involve critical care.
Case 4: HHS
An older person with infection has glucose 44 mmol/L, marked dehydration, osmolality 335 mOsm/kg, minimal ketones and confusion. Treat as HHS: cautious isotonic fluid resuscitation, potassium assessment, gradual osmolality correction, precipitant treatment and close neurologic monitoring.
14. Quick self-test
- What fasting glucose and HbA1c values meet the usual diabetes thresholds?
- Why can urine ketones be misleading during DKA recovery?
- What is the first bedside action for a conscious patient with glucose 2.8 mmol/L?
- Which electrolyte must be checked before starting IV insulin in DKA?
- Can glucose of 9 mmol/L exclude DKA in a patient taking an SGLT2 inhibitor?
Answers
- FPG ≥126 mg/dL (7.0 mmol/L) or HbA1c ≥6.5% (48 mmol/mol), confirmed if the patient is asymptomatic.
- Urine nitroprusside detects acetoacetate rather than beta-hydroxybutyrate; it may lag early and remain positive as beta-hydroxybutyrate converts during recovery.
- If awake and able to swallow, give 15–20 g fast-acting carbohydrate and recheck in 15 minutes.
- Potassium. Total body potassium is depleted and insulin can rapidly lower serum potassium.
- No. Euglycaemic DKA is possible; check blood ketones and acid–base status.
Key take-home points
- Use laboratory plasma glucose, not urine glucose or a single contaminated finger-stick, for diagnosis.
- Confirm asymptomatic diabetes; a symptomatic crisis is an emergency, not a repeat-test problem.
- HbA1c reflects recent months but fails when red-cell survival or haemoglobin is abnormal.
- Always pair severe hyperglycaemia with ketones, bicarbonate/pH, potassium, renal function and osmolality.
- Normal or moderately elevated glucose does not exclude euglycaemic DKA, especially with SGLT2 inhibitors, pregnancy or starvation.
- Prevent recurrent hypoglycaemia by reviewing the medication, meal, renal/liver function and education—not just correcting the number.
References and further reading
- NIDDK: Diabetes tests and diagnosis
- NIDDK: The A1C test
- NIDDK: Diabetes and prediabetes tests for clinicians
- American Diabetes Association: Diagnosis and classification of diabetes (Standards of Care)
- MedlinePlus: Blood glucose test
- MedlinePlus: Diabetic ketoacidosis
- MedlinePlus: Hyperosmolar hyperglycaemic state
- MedlinePlus: Hypoglycaemia
Educational note: Emergency doses and fluid/insulin protocols must follow current local, adult/paediatric, pregnancy and critical-care guidelines. Escalate early when the diagnosis or response is uncertain.
